EMPLICITI Trademark

Trademark Overview

On Wednesday, November 5, 2014, a trademark application was filed for EMPLICITI with the United States Patent and Trademark Office. The USPTO has given the EMPLICITI trademark a serial number of 86445202. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, April 5, 2025. This trademark is owned by Bristol-Myers Squibb Company. The EMPLICITI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of cancer
empliciti

General Information

Serial Number86445202
Word MarkEMPLICITI
Filing DateWednesday, November 5, 2014
Status710 - CANCELLED - SECTION 8
Status DateSaturday, April 5, 2025
Registration Number5413161
Registration DateTuesday, February 27, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 20, 2015

Trademark Statements

Description of MarkThe mark consists of the word "Empliciti" below a swirled line.
Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, April 5, 2025
Primary Code005
First Use Anywhere DateMonday, November 30, 2015
First Use In Commerce DateMonday, November 30, 2015

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Saturday, January 31, 2015ASSIGNED TO EXAMINER
Saturday, November 8, 2014NEW APPLICATION ENTERED
Friday, November 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 15, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 7, 2015NON-FINAL ACTION WRITTEN
Saturday, February 7, 2015NON-FINAL ACTION E-MAILED
Saturday, February 7, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 17, 2015TEAS PETITION TO REVIVE RECEIVED
Monday, August 17, 2015PETITION TO REVIVE-GRANTED
Monday, August 17, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2015NOTICE OF REVIVAL - E-MAILED
Wednesday, September 9, 2015ASSIGNED TO LIE
Monday, September 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 15, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 15, 2016SOU EXTENSION 1 FILED
Wednesday, June 15, 2016SOU EXTENSION 1 GRANTED
Friday, June 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2016SOU EXTENSION 2 FILED
Thursday, December 15, 2016SOU EXTENSION 2 GRANTED
Saturday, December 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 15, 2017SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2017SOU EXTENSION 3 FILED
Thursday, June 15, 2017SOU EXTENSION 3 GRANTED
Saturday, June 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, December 20, 2017TEAS PETITION TO REVIVE RECEIVED
Wednesday, December 20, 2017PETITION TO REVIVE-GRANTED
Wednesday, December 20, 2017SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, December 21, 2017NOTICE OF REVIVAL - E-MAILED
Monday, January 22, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 23, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, December 15, 2017SOU EXTENSION 4 FILED
Wednesday, December 20, 2017USE AMENDMENT FILED
Tuesday, January 23, 2018SOU EXTENSION 4 GRANTED
Tuesday, January 23, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 24, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 26, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, September 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, April 5, 2025CANCELLED SEC. 8 (6-YR)
Saturday, April 5, 2025NOTICE OF CANCELLATION SEC. 8 EMAILED
Monday, September 23, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15

Related Keywords

empliciti prevention cancer treatment human preparations pharmaceutical